Navigation Links
Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain
Date:1/4/2012

BALTIMORE, Jan. 4, 2012 /PRNewswire/ -- Arcion Therapeutics, a clinical stage biotechnology company developing topical therapies for chronic pain, today announced that it received notice of allowance for a US Patent for its high strength gel formulation of topical lidocaine, ARC-2022.  ARC-2022 is being developed by Arcion for pain associated with post-herpetic neuralgia (PHN) and shingles.  ARC-2022 has been evaluated in a single-dose Phase 1 pharmacokinetic study in adult patients with PHN.  The results indicated sustained delivery without requirement of a patch or skin-occlusion.  No safety issues were identified.

"With ARC-2022 our goal is to deliver lidocaine to the skin without the requirement of an occlusive patch.  With topical delivery, systemic toxicities and CNS side effects can be avoided and the abnormal pain signals are suppressed at the point of origination in the skin," said James N. Campbell, MD, President and CEO of Arcion.  "Issues with presently available FDA products for the treatment of neuropathic pain include limited efficacy and frequent side effects.  Patches can pose challenges to the patient, particularly when they must be applied over joints, feet, hands, hairy or sweaty skin, or areas such as the face where aesthetics come into play.  We believe ARC-2022 is an excellent candidate to address a significant market need with a product that optimizes delivery directly to the painful skin without the need for a patch." 

"This patent allowance represents the second patent in the last three months for our two topical chronic pain programs, ARC-2022 and ARC-4558.  These products now have patent protection through 2029 and beyond," commented Kerrie Brady, COO of Arcion. "We are on track to advance ARC-4558 for painful diabetic neuropathy into Phase 3 studies and ARC-2022 into further Phase 1/2 studies in 2012. ARC-4558 has received fast-track status with the FDA."


'/>"/>

SOURCE Arcion Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Arcion Therapeutics to Present ARC-4558 Phase 2b Data for the Treatment of Pain Associated With Painful Diabetic Neuropathy at Upcoming Medical Meetings
2. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
3. BioNeutral Group Receives $400,000 in Equity Financing
4. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
5. Intimate Bridge 2 Conception, Inc. Receives $4.3M
6. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
7. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
8. Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
9. Watsons Generic Yaz(R) Receives FDA Approval
10. UCSB professor receives award for graphene electronics research
11. iBio, Inc. Receives Notice from NYSE Amex Staff that Company Currently is Below Certain Continued Listing Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... This report is a professional and ... an overview analysis, the report introduces quartz tubing ... industry overview, policy analysis, and news analysis, etc. ... witnessed rapid development with key manufacturers increasing their ... mentions quartz tubing upstream raw materials and equipment, ...
(Date:12/17/2014)... Dec. 17, 2014  United Therapeutics Corporation (NASDAQ: ... as well as changes to Martine Rothblatt , ... United Therapeutics announced the promotion of ... Executive Officer and David Zaccardelli , Pharm.D. to ... with these promotions, Dr. Rothblatt,s title will change from ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  BrainStorm ... leading developer of adult stem cell technologies for neurodegenerative ... Ltd. was awarded a grant of approximately $1.1 million ... Chief Scientist (OCS).  This is the eighth year that ... the Office of the Chief Scientist, which is part ...
(Date:12/13/2014)... CanDiag, Inc., a University of North Carolina ... name to OncoTab, Inc. , “The new name ... today,” said CEO and Chief Science Officer, Dr. Pinku ... cancer diagnostics to include imaging and therapies, and our ... Founded in 2011 by Dr. Mukherjee, an Irwin Belk ...
Breaking Biology Technology:2020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2
... /Xinhua-PRNewswire-FirstCall/ -- Shengtai,Pharmaceutical, Inc. (OTC Bulletin Board: ... manufacturer and distributor in China of high-,quality, ... industry and,glucose and starch products for food, ... of Ms. Melody Shi as its Chief ...
... May 1 DermAvance Pharmaceuticals, a,privately held ... skin health and cosmetic dermatology, today announced ... Technology Partners of,Southeastern Pennsylvania (BFTP/SEP). These funds ... will be used to complete the acquisition ...
... Cell Therapy Company,s Move Driven by Commitment of Governor and ... Collaboration with Leading Stem Cell Researcher, EWING, N.J., ... its East Coast operations in Ewing, N.J., The move, ... through the New Jersey Economic Development Authority,puts StemCyte,s executives in ...
Cached Biology Technology:Shengtai Pharmaceutical, Inc. Appoints New CFO 2Shengtai Pharmaceutical, Inc. Appoints New CFO 3DermAvance Pharmaceuticals Announces Investment by Ben Franklin Technology Partners of Southeastern Pennsylvania 2StemCyte Locates East Coast Operations in New Jersey 2
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ... "Global Facial Recognition Market 2015-2019" report to ... Facial recognition is a technology ... system measures the overall facial feature of a ... the distance between eyes. Facial recognition is used ...
(Date:12/11/2014)...  That blood pressure plays a role in human health ... medical term for high blood pressure – was first described ... cuff that,s used in measuring blood pressure was invented in ... about hypertension, its triggers and its effects. In fact, recent ... the best ways to treat it. For example, ...
(Date:12/10/2014)... Dec. 9, 2014  Valencell, a leader in performance ... a staggering demand from its licensees for highly accurate, ... is not solely coming from fitness and health sectors, ... "A wearable is only as useful as the ... the ultimate driver in long-term mass consumer adoption of ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... ARBOR, Mich. Head and neck cancer patients who smoked, ... were diagnosed had worse survival outcomes than those with better ... of Michigan Comprehensive Cancer Center. "While there has been ... linked to cancer survival, the health habits a person has ...
... University College London Business PLC (UCLB) and Ocera Therapeutics ... of an exclusive worldwide licensing agreement for UCL-L1V and ... the treatment of acute hepatic encephalopathy (AHE). ... blood levels of ammonia, a highly toxic chemical that ...
... honored as the 2009 recipient of the Signature Genomic Laboratories ... 2009 Annual Clinical Genetics Meeting in Tampa, Florida. Dr. ... York General Hospital in Toronto, Canada. Dr. Chun received ... A new award in 2008, the Signature Genomics Travel Award ...
Cached Biology News:Health choices predict cancer survival, U-M study finds 2Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB 2Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB 3
... The ProteoExtract™ Protein Precipitation Kit is ... of proteins from aqueous samples. Proteomics ... the presence of non-protein impurities such ... the protein sample that interfere with ...
... luminometer provides the sensitivity and versatility you ... digital photon counting with selected photomultipliers ensure ... demands. Equipped with up to 2 reagent ... reporter gene assays as well as other ...
... high-speed analytical techniques, the AutoTrace SPE is a powerful, high-throughput workstation dedicated specifically ... loading and elution steps for large volumes aqueous solution extractions (up to 2000ml's). ... ... ...
... clear polystyrene with frosted labeling surfaces, ... cell counting. 100% integrity tested. Linkage: ... product number, created to easily match ... availability yet, please order under the ...
Biology Products: